Literature DB >> 9241407

Behavioral and emotional disturbance in individuals with Williams syndrome.

S L Einfeld1, B J Tonge, T Florio.   

Abstract

Behavioral and emotional disturbance was assessed in 70 children and adolescents with Williams syndrome. They were compared with an epidemiological control population, which was statistically controlled for age, gender, and level of mental retardation. Those with Williams syndrome were more likely to be diagnosed as suffering psychiatric disorder. The disorder was characterized by anxiety, hyperactivity, preoccupations, and inappropriate interpersonal relating. Significantly increased rates of other individual symptoms were also found, including sleep disturbance and hyperacusis. These results, considered with earlier findings, suggest that there is a valid behavior phenotype of Williams syndrome. This is frequently associated with sufficient impairment to consider inclusion of the behavior phenotype in future official taxonomies of mental disorders.

Entities:  

Mesh:

Year:  1997        PMID: 9241407     DOI: 10.1352/0895-8017(1997)102<0045:BAEDII>2.0.CO;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  40 in total

1.  Exploration of psychometric properties of the developmental behavior checklist.

Authors:  R P Hastings; T Brown; R H Mount; K F Cormack
Journal:  J Autism Dev Disord       Date:  2001-08

Review 2.  Cognitive and behavioral characteristics of children with Williams syndrome: implications for intervention approaches.

Authors:  Carolyn B Mervis; Angela E John
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-05-15       Impact factor: 3.908

3.  An atypical deletion of the Williams-Beuren syndrome interval implicates genes associated with defective visuospatial processing and autism.

Authors:  Lisa Edelmann; Aaron Prosnitz; Sherly Pardo; Jahnavi Bhatt; Ninette Cohen; Tara Lauriat; Leonid Ouchanov; Patricia J González; Elina R Manghi; Pamela Bondy; Marcela Esquivel; Silvia Monge; Marietha F Delgado; Alessandra Splendore; Uta Francke; Barbara K Burton; L Alison McInnes
Journal:  J Med Genet       Date:  2006-09-13       Impact factor: 6.318

Review 4.  Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome.

Authors:  E Walter; P K Mazaika; A L Reiss
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

5.  Evolution of Symptoms and Syndromes of Psychopathology in Young People with Mental Retardation.

Authors:  Stewart L Einfeld; Bruce J Tonge; Kylie Gray; John Taffe
Journal:  Int Rev Res Ment Retard       Date:  2006

6.  Overlap with the autism spectrum in young children with Williams syndrome.

Authors:  Bonita P Klein-Tasman; Kristin D Phillips; Catherine Lord; Carolyn B Mervis; Frank J Gallo
Journal:  J Dev Behav Pediatr       Date:  2009-08       Impact factor: 2.225

7.  Sex-dependent role of the amygdala in the development of emotional and neuroendocrine reactivity to threatening stimuli in infant and juvenile rhesus monkeys.

Authors:  Jessica Raper; Kim Wallen; Mar M Sanchez; Shannon B Z Stephens; Amy Henry; Trina Villareal; Jocelyne Bachevalier
Journal:  Horm Behav       Date:  2013-02-01       Impact factor: 3.587

8.  Abnormalities in neural processing of emotional stimuli in Williams syndrome vary according to social vs. non-social content.

Authors:  Karen E Muñoz; Andreas Meyer-Lindenberg; Ahmad R Hariri; Carolyn B Mervis; Venkata S Mattay; Colleen A Morris; Karen Faith Berman
Journal:  Neuroimage       Date:  2009-12-11       Impact factor: 6.556

9.  Viewing social scenes: a visual scan-path study comparing fragile X syndrome and Williams syndrome.

Authors:  Tracey A Williams; Melanie A Porter; Robyn Langdon
Journal:  J Autism Dev Disord       Date:  2013-08

Review 10.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.